|
|
|
Corporate Profile: Alnylam Pharmaceuticals
| Summary: |
Alnylam Pharmaceuticals is focused on the research and development of RNAi therapeutics for infectious diseases and cancer.
|
| Address (HQ): |
300 Third Street
3rd Floor
Cambridge, MA 02142 |
| Phone #'s (HQ): |
| Main |
(617) 551-8200 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(617) 551-8101 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| ALNY |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
